Literature DB >> 7681197

Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope.

B P Grubb1, D A Wolfe, D Samoil, P Temesy-Armos, H Hahn, L Elliott.   

Abstract

Recurrent vasovagally mediated episodes of hypotension and bradycardia are a common cause of recurrent syncope that can be identified by head-upright tilt table testing. Although the use of beta blockers, transdermal scopolamine, disopyramide, and fludrocortisone may be helpful in preventing further episodes, some patients are intolerant of or respond poorly to each of these agents. Following anecdotal observations, we investigated the utility of fluoxetine (a serotonin re-uptake antagonist) in preventing head-upright tilt induced hypotension/bradycardia in patients unresponsive to or intolerant of standard therapy. Sixteen patients (7 men and 9 women, mean age 42 +/- 21 years) with recurrent syncope and positive head-upright tilt studies (refractory to normal therapy) were placed on fluoxetine and restudied 5-6 weeks afterward. Three patients were intolerant of the medication. Of the 13 patients who underwent repeat tilt studies, seven patients (53% of the patients retested or 44% of the total group) were rendered tilt table negative, and, over a mean follow-up period of 19 +/- 9 months, have remained asymptomatic. We conclude that fluoxetine may be an effective therapy in patients with recurrent vasovagally mediated syncope refractory to other forms of therapy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681197     DOI: 10.1111/j.1540-8159.1993.tb01608.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  12 in total

Review 1.  Neurally mediated syncope.

Authors:  M Zaqqa; A Massumi
Journal:  Tex Heart Inst J       Date:  2000

2.  Vasodepressor Syncope.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-08

3.  Neurally Mediated Syncope.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-08

4.  Role of carotid sinus syndrome and neurocardiogenic syncope in recurrent syncope and falls in patients referred to an outpatient clinic in a district general hospital.

Authors:  A Eltrafi; D King; J H Silas; P Currie; M Lye
Journal:  Postgrad Med J       Date:  2000-07       Impact factor: 2.401

5.  Vasovagal syncope in patients with reduced left ventricular function.

Authors:  Christopher M Stanton; Phillip A Low; David O Hodge; Win-Kuang Shen
Journal:  Clin Auton Res       Date:  2007-01-09       Impact factor: 4.435

Review 6.  Neurocardiogenic syncope: aetiology and management.

Authors:  K A Gatzoulis; P K Toutouzas
Journal:  Drugs       Date:  2001       Impact factor: 9.546

7.  "Rate-drop response" cardiac pacing for vasovagal syncope. Rate-Drop Response Investigators Group.

Authors:  D G Benditt; R Sutton; M Gammage; T Markowitz; J Gorski; G Nygaard; J Fetter
Journal:  J Interv Card Electrophysiol       Date:  1999-03       Impact factor: 1.900

8.  Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis.

Authors:  Lucy Y Lei; Satish R Raj; Robert S Sheldon
Journal:  Heart Rhythm       Date:  2020-03-07       Impact factor: 6.343

Review 9.  Neurally mediated syncope and serotonin reuptake inhibitors.

Authors:  D Samoil; B P Grubb
Journal:  Clin Auton Res       Date:  1995-10       Impact factor: 4.435

10.  Exercise-induced vasodepressor syncope in a collegiate wrestler: a case study.

Authors:  J Hand
Journal:  J Athl Train       Date:  1997-10       Impact factor: 2.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.